Skip to content

Imaging the Sigma1-receptor with SA4503 and positron emission tomography in depressive disorder

Imaging the Sigma1-receptor with SA4503 and positron emission tomography in depressive disorder - The sigma1-receptor in depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29746
Enrollment
20
Registered
2006-10-13
Start date
2006-10-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Major) Depressive Disorder depression

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Fulfilling the criteria for major depression according to DSM-IV-TR criteria Informed consent. Regarded by the treating physician to have competence of judgement Age 18-50 years

Exclusion criteria

Exclusion criteria: Current use of any medication (patients must be drug-free for three weeks) except use of benzodiazepines. Drug or alcohol abuse in the past year Prior cardiovascular disease, brain disease (including former traumatic contusion) Evidence of any general medical disease, e.g. significant kidney or liver disease Abnormalities at clinical neurological examination Pregnancy ;(healthy controls): presence in the past of any psychiatric diagnosis, or the presence of a psychiatric disturbance in first-degree relatives of the subject, will be used as an exclusion criterion.

Design outcomes

Primary

MeasureTime frame
The main outcome variables will be the distribution volume, the binding potential and receptor density in the brain. Our hypothesis is that the number of sigma-receptors will be increased in persons with a depressive disorder.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)